Display options
Cite
Batra S, Baker RA, Wang T, et al. Digital health technology for use in patients with serious mental illness: a systematic review of the literature. Med Devices (Auckl). 2017;10:237-251doi: 10.2147/MDER.S144158.
Batra, S., Baker, R. A., Wang, T., Forma, F., DiBiasi, F., & Peters-Strickland, T. (2017). Digital health technology for use in patients with serious mental illness: a systematic review of the literature. Medical devices (Auckland, N.Z.), 10237-251. https://doi.org/10.2147/MDER.S144158
Batra, Sonal, et al. "Digital health technology for use in patients with serious mental illness: a systematic review of the literature." Medical devices (Auckland, N.Z.) vol. 10 (2017): 237-251. doi: https://doi.org/10.2147/MDER.S144158
Batra S, Baker RA, Wang T, Forma F, DiBiasi F, Peters-Strickland T. Digital health technology for use in patients with serious mental illness: a systematic review of the literature. Med Devices (Auckl). 2017 Oct 04;10:237-251. doi: 10.2147/MDER.S144158. eCollection 2017. PMID: 29042823; PMCID: PMC5633292.
Copy Download .nbib Format: NLM
Share it on

Med Devices (Auckl). 2017 Oct 04;10:237-251. doi: 10.2147/MDER.S144158. eCollection 2017.

Digital health technology for use in patients with serious mental illness: a systematic review of the literature.

Medical devices (Auckland, N.Z.)

Sonal Batra, Ross A Baker, Tao Wang, Felicia Forma, Faith DiBiasi, Timothy Peters-Strickland

Affiliations

  1. Department of Psychiatry, Rutgers Robert Wood Johnson Medical School, Piscataway.
  2. Global Medical Affairs, Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ.
  3. Medical Affairs, Otsuka Pharmaceutical Development and Commercialization Inc., Rockville, MD.
  4. Health Economics and Outcomes Management.
  5. Global Clinical Development, Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, NJ, USA.

PMID: 29042823 PMCID: PMC5633292 DOI: 10.2147/MDER.S144158

Abstract

BACKGROUND: As the capabilities and reach of technology have expanded, there is an accompanying proliferation of digital technologies developed for use in the care of patients with mental illness. The objective of this review was to systematically search published literature to identify currently available health technologies and their intended uses for patients with serious mental illness.

MATERIALS AND METHODS: The Medline, Embase, and BIOSIS Previews electronic databases were searched to identify peer-reviewed English language articles that reported the use of digital, mobile, and other advanced technology in patients with schizophrenia/schizoaffective disorder, bipolar disorder, and major depressive disorder. Eligible studies were systematically reviewed based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

RESULTS: Eighteen studies that met the inclusion criteria were identified. Digital health technologies (DHTs) assessed in the selected studies included mobile applications (apps), digital medicine, digital personal health records, and an electronic pill container. Smartphone apps accounted for the largest share of DHTs. The intended uses of DHTs could be broadly classified as monitoring to gain a better understanding of illness, clinical assessment, and intervention. Overall, studies indicated high usability/feasibility and efficacy/effectiveness, with several reporting validity against established clinical scales. Users were generally engaged with the DHT, and mobile assessments were deemed helpful in monitoring disease symptoms.

CONCLUSION: Rapidly proliferating digital technologies seem to be feasible for short-term use in patients with serious mental illness; nevertheless, long-term effectiveness data from naturalistic studies will help demonstrate their usefulness and facilitate their adoption and integration into the mental health-care system.

Keywords: digital medicine; health technology; mHealth; serious mental illness; smartphone applications

Conflict of interest statement

Disclosure SB is a pharmaceutical medicine fellow at Rutgers Robert Wood Johnson Medical School. RAB, TW, FF, FD, and TPS are employees of Otsuka Pharmaceutical Development and Commercialization Inc.

References

  1. J Psychosom Res. 2010 Dec;69(6):591-9 - PubMed
  2. J Med Internet Res. 2016 Jan 08;18(1):e6 - PubMed
  3. BMC Psychiatry. 2012 Oct 17;12:172 - PubMed
  4. J Nerv Ment Dis. 2010 Oct;198(10):715-21 - PubMed
  5. J Child Psychol Psychiatry. 2017 Apr;58(4):474-503 - PubMed
  6. PLoS One. 2016 May 02;11(5):e0154248 - PubMed
  7. JMIR Ment Health. 2016 Jan 06;3(1):e2 - PubMed
  8. Psychiatr Rehabil J. 2013 Dec;36(4):289-96 - PubMed
  9. JMIR Mhealth Uhealth. 2015 Nov 06;3(4):e102 - PubMed
  10. Psychiatry Res. 2014 Dec 15;220(1-2):564-70 - PubMed
  11. Health Aff (Millwood). 2009 May-Jun;28(3):w490-501 - PubMed
  12. Nature. 2016 Apr 7;532(7597):20-3 - PubMed
  13. J Ment Health. 2015;24(5):276-82 - PubMed
  14. Front Psychiatry. 2013 Aug 08;4:87 - PubMed
  15. Schizophr Bull. 2014 Nov;40(6):1244-53 - PubMed
  16. PLoS One. 2010 Oct 13;5(10):e13196 - PubMed
  17. Schizophr Bull. 2013 Sep;39(5):999-1007 - PubMed
  18. BMJ. 2009 Jul 21;339:b2700 - PubMed
  19. J Affect Disord. 2015 Nov 1;186:342-9 - PubMed
  20. PLoS One. 2015 Feb 06;10(2):e0116820 - PubMed
  21. J Affect Disord. 2016 Nov 15;205:225-233 - PubMed
  22. BMJ Open. 2014 Jan 09;4(1):e003440 - PubMed
  23. Gen Hosp Psychiatry. 2013 Jul-Aug;35(4):339-44 - PubMed
  24. BMC Psychiatry. 2013 Feb 07;13:49 - PubMed
  25. Br J Gen Pract. 2015 Dec;65(641):e813-21 - PubMed
  26. J Med Internet Res. 2013 Nov 15;15(11):e247 - PubMed
  27. Clin Psychol Psychother. 2014 Sep-Oct;21(5):427-36 - PubMed
  28. Cochrane Database Syst Rev. 2015 Jul 27;(7):MR000042 - PubMed
  29. Adm Policy Ment Health. 2013 Jul;40(4):340-3 - PubMed
  30. J Med Internet Res. 2011 Dec 31;13(4):e126 - PubMed
  31. BMC Psychiatry. 2013 Jan 23;13:34 - PubMed
  32. Schizophr Res. 2015 May;164(1-3):187-92 - PubMed
  33. J Dual Diagn. 2012 Oct;8(4):305-314 - PubMed
  34. Schizophr Bull. 2015 Mar;41(2):440-8 - PubMed
  35. Aging Ment Health. 2009 Sep;13(5):769-77 - PubMed
  36. BMJ. 2016 Mar 17;352:i1174 - PubMed
  37. J Med Internet Res. 2016 Nov 22;18(11):e309 - PubMed
  38. J Affect Disord. 2016 Aug;200:58-66 - PubMed
  39. Schizophr Bull. 2012 May;38(3):396-404 - PubMed
  40. J Affect Disord. 2016 Mar 15;193:145-50 - PubMed
  41. JMIR Ment Health. 2016 May 04;3(2):e15 - PubMed
  42. Neuropsychiatr Dis Treat. 2016 Oct 11;12 :2587-2594 - PubMed
  43. J Clin Psychiatry. 2013 Jun;74(6):e533-40 - PubMed
  44. Psychiatr Serv. 2009 Sep;60(9):1265-8 - PubMed
  45. J Med Internet Res. 2015 Jun 22;17(6):e156 - PubMed
  46. Health Aff (Millwood). 2013 Oct;32(10):1723-30 - PubMed
  47. JMIR Ment Health. 2016 Mar 01;3(1):e7 - PubMed
  48. BMC Psychiatry. 2015 Oct 14;15:250 - PubMed

Publication Types